Clinical trial
The Effect of RNS60 on ALS Biomarkers
NCT03456882 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of RNS60 on ALS Biomarkers
- Lead sponsor
- Mario Negri Institute for Pharmacological Research
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 30, 2017
- Completion date
- May 30, 2021
- Enrollment
- 147 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.